NCT02084576View on ClinicalTrials.gov

Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

February 28, 2014

Conditions
Cystoid Macular EdemaCataract
Interventions
DRUG

Nepafenac

One drop in the study eye 3 times daily for 30 days

DRUG

Ketorolac

One drop in the study eye 4 times daily for 30 days

Trial Locations (1)

70000

Hospital Oftalmologico de Brasília, Brasília

All Listed Sponsors
lead

Hospital Oftalmologico de Brasilia

OTHER

NCT02084576 - Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification | Biotech Hunter | Biotech Hunter